Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease

Nonalcoholic fatty liver disease has become the main concern of hepatologists around the world and the main research topic for identifying effective and safe therapy. Advances in the treatment of chronic viral hepatitis in recent years have opened the way towards reducing mortality in patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Cristina M. Muzica, Catalin Victor Sfarti, Tudor Cuciureanu, Laura Huiban, Carol Stanciu, Anca Trifan
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2020/6630296
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
by: Roberto Martínez-Beamonte, et al.
Published: (2020-01-01)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”
by: Abdulrahman Ismaiel, et al.
Published: (2020-01-01)

Nonalcoholic Fatty Liver Disease: A Clinical Approach and Review
by: Maitreyi Raman, et al.
Published: (2006-01-01)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
by: Anna Alisi, et al.
Published: (2011-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
by: Wenxia Lu, et al.
Published: (2016-01-01)

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
by: Şule Demir, et al.
Published: (2016-01-01)

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes
by: Krikor Kichian, et al.
Published: (2003-01-01)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
by: Caihua Wang, et al.
Published: (2019-01-01)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
by: Rajalingham Sakthiswary, et al.
Published: (2014-01-01)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
by: Bai Li, et al.
Published: (2022-01-01)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
by: Ivana Mikolasevic, et al.
Published: (2020-01-01)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
by: Yi-Sun Song, et al.
Published: (2013-01-01)

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Seon Young Ahn, et al.
Published: (2020-01-01)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
by: Hessam Yaghmaei, et al.
Published: (2024-01-01)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01)

RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
by: Kamyar Asadipooya, et al.
Published: (2019-01-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
by: Stefano Bibbò, et al.
Published: (2018-01-01)

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)

Increasing Whole Grain Intake as Part of Prevention and Treatment of Nonalcoholic Fatty Liver Disease
by: Alastair B. Ross, et al.
Published: (2013-01-01)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
by: Hwa Young Ahn, et al.
Published: (2018-01-01)

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
by: Julia Uhanova, et al.
Published: (2016-01-01)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01)

Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways
by: Yong Zou, et al.
Published: (2020-01-01)

The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery
by: Tannaz Jamialahmadi, et al.
Published: (2022-01-01)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
by: Kouichi Miura, et al.
Published: (2010-01-01)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
by: Mingliang Zhang, et al.
Published: (2021-01-01)

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
by: Changzhou Cai, et al.
Published: (2021-01-01)

Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease
by: Goh Eun Chung, et al.
Published: (2016-01-01)

Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease
by: Kadir Ozturk, et al.
Published: (2016-01-01)

Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
by: Lung-Wen Tsai, et al.
Published: (2021-01-01)

Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
by: Lian Tock, et al.
Published: (2010-01-01)

Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice
by: Gilles Willemin, et al.
Published: (2013-01-01)